ECSP099539A - Derivados de 3-cinolinacarboxamida y su uso para tratar el cáncer - Google Patents
Derivados de 3-cinolinacarboxamida y su uso para tratar el cáncerInfo
- Publication number
- ECSP099539A ECSP099539A EC2009009539A ECSP099539A ECSP099539A EC SP099539 A ECSP099539 A EC SP099539A EC 2009009539 A EC2009009539 A EC 2009009539A EC SP099539 A ECSP099539 A EC SP099539A EC SP099539 A ECSP099539 A EC SP099539A
- Authority
- EC
- Ecuador
- Prior art keywords
- cinolinacarboxamide
- derivatives
- treat cancer
- manufacture
- chemical compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/28—Cinnolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invención se refiere a compuestos químicos de formula (I) o a una de sus sales farmacéuticamente aceptables que poseen actividad inhibitoria de la quinasa CSF-1R y que en consecuencia son útiles por su actividad anticancerígena y por lo tanto en métodos de tratamiento del organismo humano o animal. La invención tambíen se refiere a procesos para la fabricación de dichos compuestos químicos, a composiciones farmacéuticas que los contienen y a su uso en la fabricación de medicamentos para utilizar en la producción de un efecto anticancerígeno en un animal de sangre caliente como un ser humano.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88658507P | 2007-01-25 | 2007-01-25 | |
US95157607P | 2007-07-24 | 2007-07-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP099539A true ECSP099539A (es) | 2009-08-28 |
Family
ID=39310013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2009009539A ECSP099539A (es) | 2007-01-25 | 2009-07-23 | Derivados de 3-cinolinacarboxamida y su uso para tratar el cáncer |
Country Status (18)
Country | Link |
---|---|
US (2) | US7723337B2 (es) |
EP (1) | EP2118072A1 (es) |
JP (1) | JP2010500988A (es) |
KR (1) | KR20090111337A (es) |
AR (1) | AR065042A1 (es) |
AU (1) | AU2008208751A1 (es) |
BR (1) | BRPI0808005A2 (es) |
CA (1) | CA2675621A1 (es) |
CL (1) | CL2008000191A1 (es) |
CO (1) | CO6190614A2 (es) |
EC (1) | ECSP099539A (es) |
IL (1) | IL199911A0 (es) |
MX (1) | MX2009007889A (es) |
PE (1) | PE20081693A1 (es) |
RU (1) | RU2009131834A (es) |
TW (1) | TW200843775A (es) |
UY (1) | UY30880A1 (es) |
WO (1) | WO2008090353A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7465795B2 (en) * | 2005-12-20 | 2008-12-16 | Astrazeneca Ab | Compounds and uses thereof |
TW200829555A (en) * | 2006-11-10 | 2008-07-16 | Astrazeneca Ab | Chemical compounds |
UY31812A (es) * | 2008-05-07 | 2010-01-05 | Astrazeneca Ab | Derivados de cinolina como inhibidores de csf-1 |
CA2837199A1 (en) * | 2011-05-23 | 2012-11-29 | Elan Pharmaceuticals, Inc. | Cinnoline compounds as inhibitor of lrrk2 kinase activity |
US9365566B2 (en) | 2012-03-27 | 2016-06-14 | Takeda Pharmaceutical Company Limited | Cinnoline derivatives |
GB201516504D0 (en) | 2015-09-17 | 2015-11-04 | Astrazeneca Ab | Imadazo(4,5-c)quinolin-2-one Compounds and their use in treating cancer |
MA43733A (fr) * | 2016-03-21 | 2018-11-28 | Astrazeneca Ab | Composés cinnolin-4-amine et leur utilisation pour traiter le cancer |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8621425D0 (en) | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
DK273689A (da) | 1988-06-06 | 1989-12-07 | Sanofi Sa | 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler |
AU634880B2 (en) | 1990-03-28 | 1993-03-04 | Otsuka Pharmaceutical Co., Ltd. | Quinoline derivative, antiulcer drug containing the same, and production of said derivative |
UA58494C2 (uk) | 1995-06-07 | 2003-08-15 | Зенека Лімітед | Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну |
GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
BR9707495A (pt) | 1996-02-13 | 1999-07-27 | Zeneca Ltd | Derivado de quinazolina processo para a preparação do mesmo composição farmacêutica e processo para a produç o de um efeito antiangiogênico e/ou de redução de permeabilidade vascular em um animal de sangue quente |
KR100489174B1 (ko) | 1996-03-05 | 2005-09-30 | 제네카-파마 소시에떼아노님 | 4-아닐리노퀴나졸린유도체 |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
IL152682A0 (en) | 2000-05-31 | 2003-06-24 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
KR20030022264A (ko) | 2000-07-07 | 2003-03-15 | 앤지오젠 파마슈티칼스 리미티드 | 신생 혈관 형성 억제제인 콜치놀 유도체 |
US20050277627A1 (en) | 2000-07-07 | 2005-12-15 | Arnould Jean C | Colchinol derivatives as vascular damaging agents |
SE0101675D0 (sv) | 2001-05-11 | 2001-05-11 | Astrazeneca Ab | Novel composition |
GB0322726D0 (en) | 2003-09-27 | 2003-10-29 | Glaxo Group Ltd | Compounds |
WO2006067445A2 (en) | 2004-12-22 | 2006-06-29 | Astrazeneca Ab | Csf-1r kinase inhibitors |
US20060264439A1 (en) | 2005-05-17 | 2006-11-23 | Supergen, Inc. | Inhibitors of polo-like kinase-1 |
GB0521563D0 (en) | 2005-10-21 | 2005-11-30 | Glaxo Group Ltd | Novel compounds |
PL2010496T3 (pl) | 2006-04-14 | 2011-01-31 | Astrazeneca Ab | 4-Anilinochinolino-3-karboksyamidy jako inhibitory kinazy CSF-1R |
TW200829555A (en) | 2006-11-10 | 2008-07-16 | Astrazeneca Ab | Chemical compounds |
-
2008
- 2008-01-23 CL CL200800191A patent/CL2008000191A1/es unknown
- 2008-01-24 AU AU2008208751A patent/AU2008208751A1/en not_active Abandoned
- 2008-01-24 UY UY30880A patent/UY30880A1/es unknown
- 2008-01-24 JP JP2009524240A patent/JP2010500988A/ja active Pending
- 2008-01-24 BR BRPI0808005-4A patent/BRPI0808005A2/pt not_active IP Right Cessation
- 2008-01-24 WO PCT/GB2008/000256 patent/WO2008090353A1/en active Application Filing
- 2008-01-24 PE PE2008000185A patent/PE20081693A1/es not_active Application Discontinuation
- 2008-01-24 EP EP08701929A patent/EP2118072A1/en not_active Withdrawn
- 2008-01-24 TW TW097102685A patent/TW200843775A/zh unknown
- 2008-01-24 MX MX2009007889A patent/MX2009007889A/es not_active Application Discontinuation
- 2008-01-24 KR KR1020097017221A patent/KR20090111337A/ko not_active Application Discontinuation
- 2008-01-24 RU RU2009131834/04A patent/RU2009131834A/ru not_active Application Discontinuation
- 2008-01-24 CA CA002675621A patent/CA2675621A1/en not_active Abandoned
- 2008-01-25 AR ARP080100319A patent/AR065042A1/es not_active Application Discontinuation
- 2008-09-15 US US12/210,588 patent/US7723337B2/en not_active Expired - Fee Related
-
2009
- 2009-07-16 IL IL199911A patent/IL199911A0/en unknown
- 2009-07-23 EC EC2009009539A patent/ECSP099539A/es unknown
- 2009-07-24 CO CO09077326A patent/CO6190614A2/es not_active Application Discontinuation
-
2010
- 2010-05-17 US US12/781,277 patent/US20110098283A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RU2009131834A (ru) | 2011-02-27 |
US20110098283A1 (en) | 2011-04-28 |
BRPI0808005A2 (pt) | 2013-07-30 |
PE20081693A1 (es) | 2009-01-18 |
TW200843775A (en) | 2008-11-16 |
EP2118072A1 (en) | 2009-11-18 |
US20090012084A1 (en) | 2009-01-08 |
UY30880A1 (es) | 2008-09-02 |
US7723337B2 (en) | 2010-05-25 |
JP2010500988A (ja) | 2010-01-14 |
CA2675621A1 (en) | 2008-07-31 |
KR20090111337A (ko) | 2009-10-26 |
AR065042A1 (es) | 2009-05-13 |
IL199911A0 (en) | 2010-04-15 |
CL2008000191A1 (es) | 2008-08-22 |
AU2008208751A1 (en) | 2008-07-31 |
WO2008090353A1 (en) | 2008-07-31 |
CO6190614A2 (es) | 2010-08-19 |
MX2009007889A (es) | 2009-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP099322A (es) | Compuestos químicos | |
UY29300A1 (es) | Compuestos quimicos | |
UY30282A1 (es) | Compuestos quimicos | |
UY29092A1 (es) | Derivados de 4-oxo-3,4-dihidroquinazolin-6-carboxamida, inhibidores de b-raf, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones | |
NI201500123A (es) | Inhibidores quinazolínicos de formas mutadas activantes del receptor del factor de crecimiento epidérmico | |
UY30547A1 (es) | Derivados n-sustituidos de la 6-piridin-4-il quinazolin-2-amina, sus estereoisomeros y sales farmacéuticamente aceptables, proceso de preparacion, composiciones y aplicaciones. | |
UY30094A1 (es) | Compuestos químicos | |
UY28990A1 (es) | Nuevos derivados de benceno 1, 3-amino carbonilo como inhibidores de b-raf, composiciones farmacéuticas que los contienen, procesos de preparación y uso. | |
UY31281A1 (es) | Aminas, benzamidas y sulfonamidas {[4-(5,6-dimetil-2-piridin-2-il-piridin-3-il) oxipiridin-2-il]amino} sustituidas, sus sales farmacéuticamente aceptables, composiciones contenniéndolas y aplicaciones. | |
UY29093A1 (es) | Derivados de 4-oxo-3. 4-dihidroquinazolin-6-carboxamida, inhibidores de b-raf, composiciones que los contienen, procesos de preparación y aplicaiones. | |
UY29458A1 (es) | Heterociclos sustituidos y usos de los mismos | |
CY1119387T1 (el) | Τριαζολοπυραζινες ως αναστολεις brd4 για χρηση στην αντιμετωπιση καρκινου | |
ECSP109934A (es) | Compuesto - 946 | |
CL2011003082A1 (es) | Compuestos derivados de [1,2,4]triazolo[1,5-a]piridina, inhibidores de jak2 o fak; composiciones farmaceuticas que los comprenden; y su uso para el tratamiento de una enfermedad hiperproliferativa. | |
ECSP099539A (es) | Derivados de 3-cinolinacarboxamida y su uso para tratar el cáncer | |
CO6781507A2 (es) | Novedosos derivados heterociclicos | |
DOP2011000361A (es) | Nuevos derivados de pirimidina y sus usos en el tratamiento del cancer y otras enfermedades | |
CU20140048A7 (es) | Novedosos derivados de purina útiles en el tratamiento del cáncer y trastornos neurodegenerativos | |
CR20130588A (es) | Halogenoalquil-1,3-oxazinas como inhibidores de la bace1 y/o bace 2 | |
NI201000050A (es) | Derivados de pirrolo [2, 3-d] pirimidina como inhibidores de proteínas quinasas b. | |
ECSP109935A (es) | Derivados de morfolino pirimidina utilizados en enfermedades relacionadas con mtor quinasa y/o pi3k | |
DOP2006000061A (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
UY34955A (es) | 4-metil-2,3,5,9,9b-pentaaza-ciclopenta[a]naftalenos | |
CR10056A (es) | [(1h-indol-5-il)-heteroariloxi]-(1-aza-biciclo[3.3.1]nonanos como ligandos colinérgicos del n-achr para el tratamiento de trastornos piscóticos y neurodegenerativos | |
UY30835A1 (es) | 8-alquinilxantinas y derivados |